Combination Regimens Stir Excitement in Advanced RCC

Expert oncologists who treat patients with advanced RCC discuss updates from clinical trials presented during the 2023 European Society for Medical Oncology Congress that further defined the treatment paradigm in advanced RCC and gave a peek into the potential future of the disease management.

Related Keywords

United States ,American ,Neeraj Agarwal ,Benjaminl Maughan ,Laurence Albiges ,American Society Of Clinical Oncology ,International Metastatic ,Onclive Peer Exchange ,Database Consortium ,European Society For Medical Oncology ,Medical Oncology ,Choices Take Steps ,Clinical Oncology ,Annual Meeting ,Cancers Symposium ,Add Option ,Clear Cell ,Lancet Oncology ,New England Journal ,Treatment Paradigm In Advanced Rcc ,Oncologists Who Treat Patients With Advanced Rcc ,D ,Charmd ,Matthewt Campbell ,Us ,Phd ,Jalan Tan ,